Suchergebnisse - "Shirotake, Suguru"

PubPharm (152)

1

New risk stratification for adjuvant nivolumab for high-risk muscle-invasive urothelial carcinoma

enthalten in: BJUI compass | 2024

von Saito, T. | Kanao, K. | Matsumoto, K. | +11

2

New risk stratification for adjuvant nivolumab for high‐risk muscle‐invasive urothelial carcinoma

enthalten in: BJUI Compass | 2024

von Saito, T. | Kanao, K. | Matsumoto, K. | +11

3

Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab : immortal time bias-corrected analysis

enthalten in: International journal of clinical oncology | 2023

von Washino, S. | Shirotake, S. | Takeshita, H. | +12

4

Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study) : 36-month follow-up results of a clinical chart review

enthalten in: International journal of urology : official journal of the Japanese Urological Association | 2023

von Yonese, J. | Hinata, N. | Masui, S. | +17

5

Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non-clear cell renal cell carcinoma : Real-world data from a Japanese multicenter retrospective study

enthalten in: International journal of urology : official journal of the Japanese Urological Association | 2023

von Izumi, K. | Inoue, M. | Washino, S. | +10

CommentIn: Int J Urol. 2023 Sep;30(9):721-722. - PMID 36653155

6

Real‐world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST‐NIVO study) : 36‐month follow‐up results of a clinical chart review

enthalten in: International Journal of Urology | 2023

von Yonese, J. | Hinata, N. | Masui, S. | +17

7

Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome

enthalten in: IJU case reports | 2022

von Nishimoto, K. | Santo, N. | Yonamine, M. | +9

8

Impact of Cytoreductive Nephrectomy Following Nivolumab Plus Ipilimumab Therapy for Patients With Advanced Renal Cell Carcinoma

enthalten in: Anticancer research | 2022

von Shirotake, S. | Miyama, Y. | Baba, Y. | +10

9

Case Study : A Japanese patient with metastatic renal cell carcinoma who achieved long-term treatment-free survival with pembrolizumab and axitinib in the KEYNOTE-426 phase III trial of pembrolizumab and axitinib versus sunitinib

enthalten in: IJU case reports | 2022

von Nishimoto, K. | Shirotake, S. | Miyama, Y. | +7

10

Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer

enthalten in: Japanese journal of clinical oncology | 2022

von Omura, M. | Kikuchi, E. | Shigeta, K. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]